World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
37572
World Ranking
11160
National Ranking
5740

Alastair M. Thompson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alastair M. Thompson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 538 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alastair M. Thompson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alastair M. Thompson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alastair M. Thompson is affiliated with Baylor College of Medicine in the United States and has contributed extensively to research in medicine, with a particular focus on oncology and cancer-related studies. Their academic work spans multiple fields including medicine, biochemistry, genetics, and molecular biology, reflecting a multidisciplinary approach to cancer research and treatment.

Their primary subfields of study include:

  • Oncology
  • Cancer Research
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology
  • Pathology and Forensic Medicine

Key research topics covered by their publications include:

  • Breast Cancer Treatment Studies
  • Cancer Genomics and Diagnostics
  • Breast Lesions and Carcinomas
  • Global Cancer Incidence and Screening
  • Cancer Cells and Metastasis
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced Breast Cancer Therapies

Thompson has published in a variety of scientific journals, with frequent appearances in:

  • Cancer Research
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • British Journal of Cancer
  • European Journal of Surgical Oncology

Several recent papers illustrate the scope of their research. These include:

  • "70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age" (2021, The Lancet Oncology)
  • "Spatial charting of single-cell transcriptomes in tissues" (2022, Nature Biotechnology)
  • "A spatially resolved single-cell genomic atlas of the adult human breast" (2023, Nature)
  • "Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer" (2022, JAMA)
  • "Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group" (2020, npj Breast Cancer)

Their collaborative network includes frequent co-authors such as:

  • Elinor J. Sawyer
  • Sarah E. Pinder
  • Deborah Collyar
  • Jelle Wesseling
  • Esther H. Lips

This profile indicates a focused career in oncology research with a substantial contribution to breast cancer studies, cancer genomics, and diagnostic methodologies. Their work also integrates advanced technologies like machine learning applied to medical imaging, highlighting a combination of clinical and computational research approaches.

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Telomere reduction in human colorectal carcinoma and with ageing

    Nicholas D. Hastie;Maureen Dempster;Malcolm G. Dunlop;Alastair M. Thompson

  • 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets

  • Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

    Jayant S Vaidya;Jayant S Vaidya;Frederik Wenz;Max Bulsara;Jeffrey S Tobias

  • HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

    Helen Davies;Dominik D. Glodzik;Sandro S. Morganella;Lucy R. Yates

  • Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.

    Jong-Ho Cha;Wen-Hao Yang;Weiya Xia;Yongkun Wei

  • Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator

    Sonia Lain;Jonathan J. Hollick;Johanna Campbell;Oliver D. Staples

  • Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

    Charlotte E Coles;Clare L Griffin;Anna M Kirby;Jenny Titley

  • Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement.

    Candace Correa;Eleanor E. Harris;Maria Cristina Leonardi;Benjamin D. Smith

  • Quantitative shear wave ultrasound elastography: initial experience in solid breast masses

    Andrew Evans;Patsy Whelehan;Kim Thomson;Denis McLean

  • Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

    Suzanne A. Eccles;Eric O. Aboagye;Simak Ali;Annie S. Anderson

  • Mathematical modelling of tumour invasion and metastasis

    A. R. A. Anderson;M. A. J. Chaplain;E. L. Newman;R. J. C. Steele

  • Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

    Sara A. Hurvitz;Miguel Martin;W. Fraser Symmans;Kyung Hae Jung

  • Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Y S Ju;L B Alexandrov;M Gerstung;I Martincorena

  • Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.

    C. McCowan;J. Shearer;P. T. Donnan;J. A. Dewar

  • Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

    Ellen R Copson;Tom C Maishman;Will J Tapper;Ramsey I Cutress

  • Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial

    Sirwan Hadad;Takayuki Iwamoto;Lee Jordan;Colin Purdie

  • A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.

    Javier E. Girardini;Javier E. Girardini;Marco Napoli;Marco Napoli;Silvano Piazza;Alessandra Rustighi;Alessandra Rustighi

  • Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

    B. Makubate;P. T. Donnan;J. A. Dewar;Alastair Thompson

  • Invasive Breast Cancer: Relationship between Shear-wave Elastographic Findings and Histologic Prognostic Factors

    Andrew Evans;Patsy Whelehan;Kim Thomson;Denis McLean

Frequent Co-Authors

Elizabeth A. Mittendorf
Elizabeth A. Mittendorf Brigham and Women's Hospital
Sarah E Pinder
Sarah E Pinder King's College London
Vicente Valero
Vicente Valero The University of Texas MD Anderson Cancer Center
Andrew Evans
Andrew Evans University of Dundee
Banu Arun
Banu Arun The University of Texas MD Anderson Cancer Center
Naoto T. Ueno
Naoto T. Ueno University of Hawaiʻi Cancer Center
Kenneth R. Hess
Kenneth R. Hess The University of Texas MD Anderson Cancer Center
Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center
Elinor J. Sawyer
Elinor J. Sawyer King's College London
Jean-Christophe Bourdon
Jean-Christophe Bourdon University of Dundee

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, it’s helpful to explore related online degrees and alternative career pathways in healthcare. A popular choice for those interested in mental health is pursuing psychiatric np programs online, which offer a flexible route toward becoming a Psychiatric Nurse Practitioner. This advanced nursing role focuses on assessing, diagnosing, and treating mental health disorders.

Other students may be drawn to the administrative side of healthcare. Earning a health administration degree online provides essential management and leadership skills for roles in hospitals, clinics, and public health organizations. For those seeking a cost-effective option, examining the cheapest online mha programs can help minimize student debt while maximizing career potential.

Nurses wishing to advance their clinical expertise can enroll in one of the best online bsn to dnp programs, which equips them for top clinical and leadership positions. Exploring these affordable and flexible online education options can help you chart a successful career in healthcare, tailored to your personal interests and professional goals.

Best Scientists Citing Alastair M. Thompson

Trending Scientists

Recently Published Articles